Venus Remedies Limited (VENUSREM) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE411B01019
Key metrics
- Market Cap
- ₹2,177 Cr
- P/E Ratio
- 18.71
- EPS
- 86.94
- Book Value
- 496.56
- P/B Ratio
- 3.24
- ROE
- 15.49%
- ROCE
- 15.77%
- Debt / Equity
- 0.02
- Net Margin
- 13.99%
- Revenue Growth
- 13.48%
- Profit Growth
- 126.83%
- Dividend Yield
- 0.63%
- 52W High
- ₹2,044.30
- 52W Low
- ₹424.00
- Market Cap Band
- small cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Venus Remedies Limited
Venus Remedies Limited engages in the pharmaceutical business in India, Latin America, Europe, the Middle East, Africa, Asia, and internationally. The company is involved in the research and development of solutions focusing on antimicrobial resistance, oncology, skin and wound care, and pain management. It also provides analgesic, analgesic and antipyretic, antibiotic, antidiabetic anticoagulant, antiemetic, antiviral, cardiac, cardiovascular, CNS, disinfectant and antiseptic, gastro therapy, gastro therapy, hepatoprotective, hormones (steroid), immunostimulating agent, iron supplements, mucolytic, muscle relaxant, neurology, respiratory, stress reliver, urology, vitamins, nutrients, minerals, and solvent products, as well as herbal medicine. The company was incorporated in 1989 and is headquartered in Panchkula, India.
- Headquarters
- Panchkula, India
- Employees
- 1,472
- Promoter Holding
- 48.62%
The full Venus Remedies Limited analysis
Create a free account to open the complete VENUSREM deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.